Gene Query: PPP6R2

Dataset Description Geneva Score
The effect of PPARG inhibition on human angiomyolipoma cells 21.49
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 16.5
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 15.63
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 15.07
SNHG5 siRNA knock down in HCT116 cells 15.02
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 14.5
Global analyses of the effect of different cellular contexts on microRNA targeting 14.5
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 14.19
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 13.39
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 13.31
Searching for target genes of miR-508/509/506/514 in HCT116 cells 13.24
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 13.18
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 12.33
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 11.86
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 11.68
Transcriptomic analysis of human tonsillar TFH subsets 11.62
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 11.55
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 11.54
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 11.32
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 11.19
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 11.04
circRNA-sequencing 10.97
RNA-seq of tumor cells following angiopellosis extravasation 10.69
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 10.48
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 10.44
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 10.15
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 10.01
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 9.82
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 9.73
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 9.63
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 9.5
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 9.44
Genome wide expression change in LCC2 and MCF-7 cells 9.31
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 9.26
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 9.26
Intrahepatic MAIT cell gene expression revealed by RNA-seq 9.11
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 9.01
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 8.89
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 8.75
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 8.71
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 8.71
MARS Seq data from human cortical organoids 8.61
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 8.56
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 8.56
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 8.53
RNA-sequencing of human liver tissue 8.45
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 8.4
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 8.4
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 8.4
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 8.4
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 8.38
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 8.35
DART-seq: an antibody-free method for global m6A detection 8.33
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 8.31
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 8.31
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 8.26
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 8.22
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 8.18
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 8.0
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 7.99
METTL3 promotes translation in human cancer cells 7.91
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 7.87
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 7.84
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 7.82
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 7.74
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 7.68
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 7.66
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 7.63
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 7.6
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 7.54
BAF controls genome accessibility 7.4
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 7.26
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 7.26
ARID1A and ARID1B loss in HCT116 cells 7.25
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 7.16
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 7.08
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 7.06
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 7.01
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 6.98
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 6.94
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 6.93
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 6.92
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 6.88
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 6.87
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 6.85
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 6.85
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 6.82
Mechanistic Model-Guided Study of Embryonic Morphogenesis 6.79
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 6.75
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 6.75
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 6.73
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 6.71
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 6.64
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 6.58
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 6.57
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 6.54
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 6.51
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 6.49
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 6.48
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 6.4
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 6.38
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 6.38
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 6.35
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 6.32
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 6.31
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 6.29
Hepatitis C virus functionally sequesters miR-122 6.29
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 6.24
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 6.2
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 6.19
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 6.19
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 6.18
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 6.17
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 6.13
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 6.13
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 6.12
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 6.11
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 6.09
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 6.07
MOF acetyl transferase regulates transcription and respiration in mitochondria 6.03
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 5.98
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 5.98
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 5.96
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 5.94
Total RNA sequencing of WT intestinal orgaonids. 5.93
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 5.92
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 5.91
PNET animal model: new insights (II) 5.9
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 5.85
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 5.84
RNA-seq of YB5 cells treated with Proscillaridin A 5.82
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 5.81
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 5.8
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 5.79
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 5.79
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 5.75
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 5.74
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 5.68
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 5.68
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 5.62
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 5.6
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 5.59
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 5.59
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 5.52
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 5.52
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 5.51
Stem and effector CD8 T-cells from human cancers 5.46
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 5.46
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 5.46
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 5.37
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 5.35
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 5.33
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 5.33
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 5.32
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 5.31
NHLRC1 re-expression in cancer cells 5.31
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 5.29
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 5.26
RNA-seq of cells with TET1 knockout 5.25
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 5.24
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 5.24
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 5.2
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 5.2
mRNA expression profile of Lymphocytes by high-throuput sequencing 5.19
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 5.18
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 5.18
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 5.15
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 5.14
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 5.1
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 5.1
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 5.08
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 5.08
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 5.07
SRSF1 role in cellular gene expression and splicing 5.07
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 5.06
Characterization of parental and rociletinib-resistant derived H1975 cell lines 5.05
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 5.05
TT-Seq captures the human transient transcriptome 5.04
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 5.04
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 5.02
Paxillin regulates genomic networks in prostate cancer [PC3] 4.96
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 4.96
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 4.96
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 4.95
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 4.95
Transcriptional responses of melanoma cells to BRAF inhibition 4.95
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 4.94
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 4.94
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 4.91
Genome-wide identification of cancer-specific alternative splicing in circRNA 4.9
MYC dependent mRNA translation shapes gene expression and cell biology 4.89
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 4.87
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 4.86
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 4.85
Dtx3L and Androgen Signaling in Prostate Cancer 4.83
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 4.82
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 4.82
RNA-seq in transgenic cells 4.72
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 4.7
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 4.7
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 4.65
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 4.58
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 4.57
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 4.55
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 4.53
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 4.51
Landscape and variation of RNA secondary structure across the human transcriptome 4.49
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 4.49
Evaluating pre-clinical models for studying NASH driven HCC. 4.48
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 4.47
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 4.43
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 4.39
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 4.37
Transcriptome of U251 cells overexpression complement component 7 4.36
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 4.36
Real-time observation of light-controlled transcription in living cells 4.34
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 4.33
Intron retention induced by microsatellite expansions as a disease biomarker. 4.32
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 4.28
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 4.26
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 4.26
Gene profiling of human adult and pediatric liver cancer cells 4.25
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 4.23
4.19
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 4.19
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 4.18
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 4.18
METTL3 and WTAP 4.18
A transcriptome-wide divergence in protein translation scales with LIN28B expression 4.15
CD73 knockdown effect in pancreatic cancer cell lines 4.14
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 4.11
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 4.06
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 4.05
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 4.04
Expression and functions of long noncoding RNAs during human T helper cell differentiation 4.04
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 4.03
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 4.03
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 4.03
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 4.02
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 4.01
RNA-seq in HepG2 and IMR90 cells 3.98
Evolution of a transcriptional regulator from a transmembrane nucleoporin 3.98
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 3.92
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 3.92
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 3.87
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 3.84
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 3.81
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 3.8
Loss of CREBBP results in gene expression repression in lymphoma cells 3.8
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 3.72
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 3.72
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 3.71
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 3.68
Transcriptome analyses of human pancreatic islets and pseudoislets 3.64
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 3.63
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 3.62
Transcriptional changes in lymphoma cells induced by LSD1 depletion 3.62
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 3.62
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 3.6
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 3.57
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 3.52
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 3.5
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 3.5
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA 3.49
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 3.47
Global gene expression profile of dasatinib-resistant RCH-ACV cells 3.46
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 3.45
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 3.43
X-Ray induced DNA-Hydroxymethylation changes 3.4
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 3.3
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 3.27
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 3.24
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 3.23
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 3.23
Iron response of HepG2 cells 3.21
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 3.2
Differences in miRNA Detection Levels are Technology and Sequence Dependent 3.2
Differences in miRNA Detection Levels are Technology and Sequence Dependent [NGS] 3.2
The effect of Abl kinases on non-small cell carcinoma global transcriptome 3.2
Widespread regulated alternative splicing of single codons accelerates proteome evolution 3.03
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 3.02
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 3.02
An siRNA screen identifies CHD4 as a target for epigenetic therapy 3.02
Gene expression in GBM with Cav3.2 inhibition 3.01
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 2.98
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 2.96
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 2.93
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 2.93
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 2.9
Illumina Total RNA-seq in HeLa 2.84
Downregulation of DDX5/DDX17 and REST 2.81
An optimization system for isolating and sequencing of single human colon cancer cells 2.8
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 2.8
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 2.8
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 2.76
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 2.75
Discovering human diabetes-risk gene function with genetics and physiological assays 2.74
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 2.67
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 2.67
Proteomics identifies a marker signature of MAPKi resistance in melanoma 2.66
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 2.65
Targeted enhancer activation by a subunit of the integrator complex 2.63
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 2.62
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 2.59
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 2.54
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 2.54
Genome wide miR-191 target profile determined by RIP and gene expression profiling 2.54
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 2.53
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 2.52
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 2.52
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 2.52
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 2.49
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 2.45
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 2.45
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 2.42
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 2.4
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 2.38
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 2.31
A practical evaluation of alignment algorithms for RNA variant calling analysis 2.3
Differential responses of human fetal brain neural stem cells to Zika virus infection 2.3
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 2.29
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 2.27
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 2.27
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 2.26
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.24
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 2.23
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 2.14
Silencing SPIB in attached and floating state of H1703 lung cancer cells 2.13
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 2.13
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 2.12
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 2.12
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 2.11
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 2.1
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 2.1
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 2.08
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 2.07
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 2.06
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 2.04
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 2.04
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 2.02
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 2.0
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 2.0
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 1.98
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 1.95
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 1.93
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 1.92
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 1.88
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 1.85
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 1.85
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 1.84
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 1.83
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 1.83
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 1.81
ADAR1-editing of cellular and measles virus-derived duplex RNA 1.81
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 1.81
Gene expression analysis upon mtDNA depletion 1.8
Gene expression analysis upon mtDNA depletion [RNA-seq] 1.8
Ectoderm specification of H1 human embryonic stem cells 1.79
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 1.78
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 1.76
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 1.75
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 1.75
Investigate A2M treatment on human prostate cancer xenograft in mice 1.75
Investigate A2M treatment on human prostate cancer and mouse liver 1.75
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 1.7
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.69
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 1.69
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 1.67
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 1.66
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 1.66
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 1.65
Identification of renal resident macrophages across species [C1] 1.62
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 1.6
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 1.59
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 1.59
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 1.57
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 1.57
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 1.56
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 1.54
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons 1.46
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 1.45
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 1.44
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 1.44
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 1.44
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 1.44
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.43
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 1.41
H1609088 Human RNA-Sequencing 1.41
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 1.4
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 1.39
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 1.38
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 1.35
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 1.34
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 1.3
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 1.27
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.26
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 1.26
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 1.25
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 1.25
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 1.24
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 1.22
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 1.22
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 1.22
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 1.17
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.16
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.16
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 1.14
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 1.14
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 1.13
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 1.11
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 1.11
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 1.09
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 1.09
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.06
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 0.96
N6-methyladenine DNA Modification in Glioblastoma 0.96
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 0.91
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 0.89
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 0.88
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 0.88
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.88
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 0.87
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 0.86
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 0.86
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.84
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 0.83
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 0.83
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 0.83
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.8
The bromodomain protein BRD4 regulates splicing during heat shock 0.79
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.78
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.78
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 0.78
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 0.77
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 0.77
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.75
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.72
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.72
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 0.71
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.69
The role of m6A/m-RNA methylation in stress response regulation 0.69
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.64
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.64
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 0.63
miRNAs affected by antagomiR-17 treatment 0.61
Energy Metabolism during Anchorage-Independence 0.61
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 0.6
DAOY-Notch1/Notch2 knockout: transcriptome comparison 0.59
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 0.57
Microprocessor mediates transcription termination in long noncoding microRNA genes 0.55
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.55
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 0.53
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 0.53
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.53
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 0.52
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.52
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.52
Deep RNA sequencing of the human placental transcriptome 0.52
Metabolism as an early predictor of DPSCs aging 0.51
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 0.47
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 0.47
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 0.47
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 0.47
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.47
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.43
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.43
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 0.41
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 0.38
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 0.35
Function and hormonal regulation of GATA3 in human first trimester placentation 0.35
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.34
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.33
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 0.29
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 0.27
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.25
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.24
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.24
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.21
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.2
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.2
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 0.2
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.17
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 0.16
naive T cell heterogeneity after neonatal thymectomy 0.14
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.12
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.12
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.12
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 0.09
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.08
Hepatic transcriptome of pediatric hepatoblastoma. 0.08
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.07
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 0.06
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.05
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.04
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 0.04
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 0.04
Subtle asymmetry of gene expression in embryonic and foetal human brains 0.03
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 0.03
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.0
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation